COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

被引:124
|
作者
Landstra, Cyril P. [1 ]
de Koning, Eelco J. P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands
来源
关键词
diabetes; COVID-19; SARS-CoV-2; coronavirus; severity; mortality; comorbidities; treatment; INSULIN-SECRETION; SYSTEM INHIBITORS; OXIDATIVE STRESS; TYPE-2; MORTALITY; HYPERGLYCEMIA; CORONAVIRUS; OUTCOMES; PREVALENCE; COMORBIDITIES;
D O I
10.3389/fendo.2021.649525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced beta-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Atrial fibrillation as a risk factor of severe course of COVID-19
    Mielczarek, A.
    Kasprzak, J. D.
    Plewka, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 413 - 413
  • [32] Severe mental illness is associated with increased mortality and severe course of COVID-19
    Barcella, Carlo Alberto
    Polcwiartek, Christoffer
    Mohr, Grimur Hognason
    Hodges, Gethin
    Sondergaard, Kathrine
    Niels Bang, Casper
    Andersen, Mikkel Porsborg
    Fosbol, Emil
    Kober, Lars
    Schou, Morten
    Torp-Pedersen, Christian
    Kessing, Lars Vedel
    Gislason, Gunnar
    Kragholm, Kristian
    ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 82 - 91
  • [33] Understanding of Patients with Severe COVID-19 Using Lung Ultrasound
    Yang, Seo-Hee
    Park, Eun Ju
    Kim, Jung-Hyun
    Song, Jin Woo
    Cho, Young-Jae
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2025, 88 (02) : 380 - 387
  • [34] The role of HLA genotypes in understanding the pathogenesis of severe COVID-19
    Fatemeh Arab
    Samaneh Mollazadeh
    Farnaz Ghayourbabaei
    Meysam Moghbeli
    Ehsan Saburi
    Egyptian Journal of Medical Human Genetics, 24
  • [35] The role of HLA genotypes in understanding the pathogenesis of severe COVID-19
    Arab, Fatemeh
    Mollazadeh, Samaneh
    Ghayourbabaei, Farnaz
    Moghbeli, Meysam
    Saburi, Ehsan
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2023, 24 (01)
  • [36] Genetic risks and association with severe COVID-19 among global populations
    Mauleekoonphairoj, John
    Vongpunsawad, Sompong
    Khongphatthanayothin, Apichai
    Nademanee, Koonlawee
    Poovorawan, Yong
    PATHOGENS AND GLOBAL HEALTH, 2021, 115 (04) : 209 - 210
  • [37] Rapid COVID-19 rebound in a severe COVID-19 patient during 20-day course of Paxlovid
    Wang, Yu
    Chen, Xubo
    Xiao, Wenying
    Zhao, Danyang
    Feng, Liuliu
    JOURNAL OF INFECTION, 2022, 85 (05) : E134 - E136
  • [38] COVID-19 in people with diabetes: understanding the reasons for worse outcomes
    Apicella, Matteo
    Campopiano, Maria Cristina
    Mantuano, Michele
    Mazoni, Laura
    Coppelli, Alberto
    Prato, Stefano Del
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (09): : 782 - 792
  • [39] Severe Covid-19
    Berlin, David A.
    Gulick, Roy M.
    Martinez, Fernando J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2451 - 2460
  • [40] COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
    Al-kuraishy, Hayder Mutter
    Al-Gareeb, Ali Ismail
    Mostafa-Hedeab, Gomaa
    Dubey, Rupal
    Prabhakar, Pranav Kumar
    Batiha, Gaber El-Saber
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (04) : 494 - 506